Direxion Shares ETF Trust (LABU)
Management Company · ARCX · Series S000049373 · View on SEC EDGAR ↗
- Net assets
- $518.9M
- Holdings
- 161
- As of
- April 30, 2026 stale
- Top 10 holdings weight
- 27.25%
- Effective number of positions
- 53.2
- Positions above 1%
- 19
On this page
- Fund flows Money flowing in and out of the fund each month, from N-PORT filings.
- Holdings Every position the fund currently holds, with weights.
- Sector breakdown How the fund's holdings split across market sectors.
- Institutional owners 13F institutions that report holding this ETF.
- Similar funds Other funds with overlapping holdings or comparable size.
Fund flows (SEC-reported)
- Last month (Apr 2026)
- -$78.1M
- Quarter ending Apr 2026
- -$110.0M
- Trailing 12 months
- -$927.6M
May 2025 – Apr 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 161 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| DREYFUS GOVERNMENT CASH MANAGE | — | $41.0M | 7.90 | 40,990,416 | STIV | US |
| GOLDMAN FINANCIAL | — | $34.6M | 6.66 | 34,559,954 | STIV | US |
| Unknown security | — | $14.4M | 2.78 | 1 | DE | US |
| GOLDMAN SACHS LIQ ES FD A | — | $9.4M | 1.82 | 9,422,419 | STIV | US |
| Apellis Pharmaceuticals Inc | 03753U106 | $8.0M | 1.53 | 194,250 | EC | US |
| Unknown security | — | $7.9M | 1.52 | 1 | DE | US |
| Revolution Medicines Inc | 76155X100 | $7.0M | 1.35 | 48,748 | EC | US |
| Travere Therapeutics Inc | 89422G107 | $6.9M | 1.33 | 164,067 | EC | US |
| ARROWHEAD PHARMACEUTICALS INC | 04280A100 | $6.1M | 1.18 | 83,558 | EC | US |
| Twist Bioscience Corporation | 90184D100 | $6.1M | 1.17 | 103,603 | EC | US |
| Summit Therapeutics Inc. | 86627T108 | $6.0M | 1.15 | 278,847 | EC | US |
| Alkermes PLC | G01767105 | $5.9M | 1.14 | 174,823 | EC | IE |
| TG Therapeutics Inc | 88322Q108 | $5.8M | 1.13 | 173,080 | EC | US |
| Madrigal Pharmaceuticals Inc | 558868105 | $5.8M | 1.12 | 11,249 | EC | US |
| Unknown security | — | $5.7M | 1.10 | 1 | DE | US |
| Beam Therapeutics Inc. | 07373V105 | $5.6M | 1.09 | 186,154 | EC | US |
| Apogee Therapeutics Inc. | 03770N101 | $5.4M | 1.04 | 65,006 | EC | US |
| Scholar Rock Holding Corp. | 80706P103 | $5.2M | 1.01 | 112,425 | EC | US |
| PRAXIS PRECISION MEDICINES INC | 74006W207 | $5.2M | 1.00 | 16,345 | EC | US |
| EXELIXIS INC | 30161Q104 | $5.2M | 1.00 | 116,281 | EC | US |
| Mirum Pharmaceuticals Inc. | 604749101 | $5.1M | 0.99 | 52,917 | EC | US |
| Unknown security | — | $5.1M | 0.98 | 1 | DE | US |
| United Therapeutics Corporation | 91307C102 | $5.1M | 0.98 | 8,914 | EC | US |
| Natera Inc. | 632307104 | $5.1M | 0.98 | 24,696 | EC | US |
| Celcuity Inc. | 15102K100 | $5.1M | 0.98 | 41,941 | EC | US |
| CRISPR Therapeutics AG | H17182108 | $5.1M | 0.98 | 97,235 | EC | CH |
| Krystal Biotech Inc | 501147102 | $5.0M | 0.96 | 19,037 | EC | US |
| Protagonist Therapeutics Inc | 74366E102 | $5.0M | 0.96 | 50,321 | EC | US |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | $4.9M | 0.95 | 37,476 | EC | US |
| Incyte Corporation. | 45337C102 | $4.9M | 0.94 | 51,287 | EC | US |
| CG Oncology Inc. | 156944100 | $4.9M | 0.94 | 73,170 | EC | US |
| Cytokinetics Inc | 23282W605 | $4.9M | 0.94 | 76,297 | EC | US |
| NUVALENT INC | 670703107 | $4.9M | 0.94 | 48,521 | EC | US |
| Ionis Pharmaceuticals, Inc. | 462222100 | $4.9M | 0.94 | 64,911 | EC | US |
| Bridgebio Pharma Inc | 10806X102 | $4.8M | 0.93 | 68,003 | EC | US |
| Vaxcyte Inc | 92243G108 | $4.8M | 0.93 | 84,388 | EC | US |
| Kymera Therapeutics Inc | 501575104 | $4.8M | 0.93 | 59,553 | EC | US |
| Biogen Inc | 09062X103 | $4.8M | 0.93 | 25,484 | EC | US |
| Cogent Biosciences Inc. | 19240Q201 | $4.8M | 0.93 | 134,554 | EC | US |
| PTC Therapeutics, Inc. | 69366J200 | $4.8M | 0.93 | 73,928 | EC | US |
| Insmed Inc | 457669307 | $4.7M | 0.92 | 34,830 | EC | US |
| ALNYLAM PHARMACEUTICALS INC | 02043Q107 | $4.7M | 0.90 | 15,151 | EC | US |
| Roivant Sciences Ltd | G76279101 | $4.7M | 0.90 | 164,121 | EC | BM |
| Halozyme Therapeutics Inc | 40637H109 | $4.6M | 0.90 | 73,023 | EC | US |
| Arcutis Biotherapeutics Inc. | 03969K108 | $4.6M | 0.88 | 196,991 | EC | US |
| Spyre Therapeutics Inc | 00773J202 | $4.6M | 0.88 | 61,270 | EC | US |
| Soleno Therapeutics Inc | 834203309 | $4.5M | 0.87 | 85,699 | EC | US |
| AbbVie Inc. | 00287Y109 | $4.5M | 0.87 | 21,322 | EC | US |
| Amgen Inc. | 031162100 | $4.5M | 0.86 | 12,853 | EC | US |
| REGENERON PHARMACEUTICALS INC | 75886F107 | $4.4M | 0.85 | 6,267 | EC | US |
Page 1
of 4
← Previous
Next →
Sector breakdown
Healthcare
77.1%
Other/Unmapped
22.9%
Institutional owners (13F) 40 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | $89,616,280 | 20.41% | 306,800 | Put option | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $83,073,240 | 18.92% | 284,400 | Call option | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $80,824,070 | 18.40% | 276,700 | Put option | June 30, 2026 |
| JANE STREET GROUP, LLC | $59,938,920 | 13.65% | 205,200 | Put option | June 30, 2026 |
| CITADEL ADVISORS LLC | $46,794,420 | 10.66% | 160,200 | Call option | June 30, 2026 |
| JANE STREET GROUP, LLC | $25,938,480 | 5.91% | 88,800 | Call option | June 30, 2026 |
| GOLDMAN SACHS GROUP INC | $17,126,991 | 3.90% | 58,634 | Shares | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9,585,262 | 2.18% | 32,815 | Shares | June 30, 2026 |
| Tower Research Capital LLC (TRC) | $6,295,047 | 1.43% | 21,551 | Shares | June 30, 2026 |
| GTS SECURITIES LLC | $5,100,066 | 1.16% | 17,460 | Shares | June 30, 2026 |
| TWO SIGMA SECURITIES, LLC | $1,771,294 | 0.40% | 6,064 | Shares | June 30, 2026 |
| Bank of New York Mellon Corp | $1,533,525 | 0.35% | 5,250 | Shares | June 30, 2026 |
| McGuire Investment Group, LLC | $1,525,638 | 0.35% | 5,223 | Shares | June 30, 2026 |
| CIBC Bancorp USA Inc. | $1,387,475 | 0.32% | 4,750 | Shares | June 30, 2026 |
| Allworth Financial LP | $1,234,123 | 0.28% | 4,225 | Shares | June 30, 2026 |
| Ethos Financial Group, LLC | $968,312 | 0.22% | 3,315 | Shares | June 30, 2026 |
| Walleye Trading LLC | $788,670 | 0.18% | 2,700 | Put option | June 30, 2026 |
| SBI Securities Co., Ltd. | $675,043 | 0.15% | 2,311 | Shares | June 30, 2026 |
| JANE STREET GROUP, LLC | $561,124 | 0.13% | 1,921 | Shares | June 30, 2026 |
| Walleye Trading LLC | $531,914 | 0.12% | 1,821 | Shares | June 30, 2026 |
| BANK OF AMERICA CORP /DE/ | $478,752 | 0.11% | 1,639 | Shares | June 30, 2026 |
| Valued Retirements, Inc. | $454,216 | 0.10% | 1,555 | Shares | June 30, 2026 |
| HighTower Advisors, LLC | $408,940 | 0.09% | 1,400 | Shares | June 30, 2026 |
| CIBC Private Wealth Group LLC | $351,038 | 0.08% | 3,750 | Shares | Sept. 30, 2025 |
| Simmons Bank | $349,060 | 0.08% | 1,195 | Shares | June 30, 2026 |
| Variant Private Wealth, LLC | $319,164 | 0.07% | 1,093 | Shares | June 30, 2026 |
| UBS Group AG | $297,942 | 0.07% | 1,020 | Shares | June 30, 2026 |
| HALBERT HARGROVE GLOBAL ADVISORS, LLC | $292,100 | 0.07% | 1,000 | Shares | June 30, 2026 |
| MILLENNIUM MANAGEMENT LLC | $292,100 | 0.07% | 1,000 | Shares | June 30, 2026 |
| XTX Topco Ltd | $274,574 | 0.06% | 940 | Shares | June 30, 2026 |
| Sheaff Brock Investment Advisors, LLC | $243,880 | 0.06% | 4,000 | Shares | March 31, 2025 |
| JPMORGAN CHASE & CO | $66,503 | 0.02% | 228 | Shares | June 30, 2026 |
| Steward Partners Investment Advisory, LLC | $29,210 | 0.01% | 100 | Shares | June 30, 2026 |
| BANK OF MONTREAL /CAN/ | $14,605 | 0.00% | 50 | Shares | June 30, 2026 |
| PayPay Securities Corp | $11,976 | 0.00% | 41 | Shares | June 30, 2026 |
| Larson Financial Group LLC | $8,937 | 0.00% | 31 | Shares | June 30, 2026 |
| MATHER GROUP, LLC. | $3,861 | 0.00% | 13 | Shares | June 30, 2026 |
| TORONTO DOMINION BANK | $2,576 | 0.00% | 9 | Shares | June 30, 2026 |
| Spire Wealth Management | $1,183 | 0.00% | 4 | Shares | June 30, 2026 |
| Covestor Ltd | $76 | 0.00% | 261 | Shares | June 30, 2026 |
Peer funds
More from this issuer
| Fund | AUM |
|---|---|
| SOXL Direxion Shares ETF Trust | $16.9B |
| SPXL Direxion Shares ETF Trust | $5.9B |
| TSLL Direxion Shares ETF Trust | $5.0B |
| TECL Direxion Shares ETF Trust | $4.7B |
| TMF Direxion Shares ETF Trust | $2.7B |
| FAS Direxion Shares ETF Trust | $2.0B |
| SOXS Direxion Shares ETF Trust | $1.9B |
| KORU Direxion Shares ETF Trust | $1.6B |
| TNA Direxion Shares ETF Trust | $1.5B |
| MUU Direxion Shares ETF Trust | $1.4B |
Similar by size
| Fund | AUM |
|---|---|
| FDHY Fidelity Covington Trust | $521.9M |
| IDGT iShares Trust | $522.0M |
| DDM ProShares Trust | $523.4M |
| CSM ProShares Trust | $524.0M |
| MSTU ETF Opportunities Trust | $525.4M |
| FNY First Trust Exchange-Traded Alp… | $518.2M |
| VBND ETF Series Solutions | $510.2M |
| FDEM Fidelity Covington Trust | $508.1M |
| LQDH iShares U.S. ETF Trust | $505.8M |
| QFLR Innovator ETFs Trust | $505.6M |